US 8268999
Tri-cyclic pyrazolopyridine kinase inhibitors
granted A61PA61P11/00A61P11/06
Quick answer
US patent 8268999 (Tri-cyclic pyrazolopyridine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P25/00, A61P29/00